NYSEARCA:RMED - NYSE Arca - US74933X3026 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
---|---|---|---|---|---|---|---|
Revenue YoY % growth | 259K -79.65% | 22K -91.51% | 14K -36.36% | 1.969M 13,964.29% | 8.813M 347.59% | 21.287M 141.54% | |
EBITDA YoY % growth | -33.031M 35.05% | -27.701M 16.14% | -22.368M 19.25% | N/A | N/A | N/A | |
EBIT YoY % growth | -35.401M 32.71% | -29.266M 17.33% | -22.789M 22.13% | -72.726M -219.13% | -3.305M 95.46% | 4.121M 224.70% | |
Operating Margin | -13,668.34% | -133,027.27% | -162,778.57% | -3,693.55% | -37.50% | 19.36% | |
EPS YoY % growth | -1,580.50 70.87% | N/A 87.69% | N/A | -12.25 | -0.32 97.42% | 0.30 193.55% |
All data in USD
Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | -0.31 97.72% | -0.23 94.62% | -0.17 | -0.13 99.46% | -0.12 60.26% | -0.07 69.57% | -0.01 94.12% | 0.05 138.46% | 0.02 116.67% | 0.08 214.29% | 0.14 1,500.00% |
Revenue Q2Q % growth | 214.2K 4,184.00% | 693.6K | 979.2K | 1.479M 1,640.00% | 1.673M 681.05% | 2.429M 250.20% | 3.232M 230.07% | 4.641M 213.79% | 4.264M 154.87% | 5.59M 130.14% | 6.793M 110.18% |
EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Q2Q % growth | -1.846M 62.57% | -1.652M 61.04% | -1.408M 82.65% | -1.163M 88.82% | -1.193M 35.36% | -795.6K 51.85% | -163.2K 88.41% | 724.2K 162.28% | 285.6K 123.93% | 1.081M 235.87% | 2.03M 1,343.87% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2023 Q2Q % growth | -24.65 -82.59% | -0.35 | -24.30 | -6,987.00% |
Q3 2022 Q2Q % growth | -4.36 92.42% | -8.16 | 3.80 | 46.57% |
Q2 2022 Q2Q % growth | -13.50 -954.69% | -8.16 | -5.34 | -65.44% |
Q1 2022 Q2Q % growth | -13.50 -444.35% | -8.67 | -4.83 | -55.71% |
Q4 2021 Q2Q % growth | -61.50 65.93% | -43.61 | -17.89 | -41.04% |
Q3 2021 Q2Q % growth | -57.50 64.62% | -40.29 | -17.21 | -42.72% |
Q2 2021 Q2Q % growth | -1.28 99.76% | -2.94 | 1.66 | 56.43% |
Q1 2021 Q2Q % growth | -2.48 99.65% | -3.00 | 0.52 | 17.30% |
Q4 2020 Q2Q % growth | -180.50 79.94% | -127.50 | -53.00 | -41.57% |
Q3 2020 Q2Q % growth | -162.50 90.00% | -161.93 | -0.57 | -0.36% |
Q2 2020 Q2Q % growth | -537.50 62.93% | -286.88 | -250.63 | -87.36% |
Q1 2020 Q2Q % growth | -700.00 51.72% | -439.88 | -260.13 | -59.14% |
Q4 2019 Q2Q % growth | -900.00 | -1,470.50 | 570.50 | 38.80% |
Q3 2019 Q2Q % growth | -1,625.00 | -1,181.50 | -443.50 | -37.54% |
Q2 2019 Q2Q % growth | -1,450.00 | -1,245.25 | -204.75 | -16.44% |
Q1 2019 Q2Q % growth | -1,450.00 | -484.18 | -965.82 | -199.47% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2023 Q2Q % growth | 85K 844.44% | 71.4K | 13.6K | 19.05% |
Q4 2022 Q2Q % growth | -100.00% | % | ||
Q3 2022 Q2Q % growth | -100.00% | % | ||
Q2 2022 Q2Q % growth | 5K -44.44% | 5K | % | |
Q1 2022 Q2Q % growth | 9K -99.19% | 9K | % | |
Q4 2021 Q2Q % growth | 5K | 357K | -352K | -98.60% |
Q3 2021 Q2Q % growth | 5K -92.65% | 714K | -709K | -99.30% |
Q2 2021 Q2Q % growth | 9K -95.29% | 1.242M | -1.233M | -99.28% |
Q1 2021 Q2Q % growth | 1.118M -18.63% | 1.001M | 117.211K | 11.71% |
Q4 2020 Q2Q % growth | -100.00% | 1.592M | -1.592M | -100.00% |
Q3 2020 Q2Q % growth | 68K -96.44% | 1.1M | -1.032M | -93.82% |
Q2 2020 Q2Q % growth | 191K -91.13% | 565.59K | -374.59K | -66.23% |
Q1 2020 Q2Q % growth | 1.374M -21.40% | 1.614M | -240K | -14.87% |
Q4 2019 Q2Q % growth | 1.39M | 2.092M | -702K | -33.56% |
Q3 2019 Q2Q % growth | 1.908M | 2.072M | -164K | -7.92% |
Q2 2019 Q2Q % growth | 2.153M | 2.102M | 51K | 2.43% |
Q1 2019 Q2Q % growth | 1.748M | 1.258M | 490K | 38.95% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | 0% | 0% | 0% | -1042.72% |
Revenue | 0% | 0% | 0% | 0.56% |